Scarica l'app Stockscreener
15.60
0.57%
-0.09
Precedente Chiudi:
$15.69
Aprire:
$15.58
Volume 24 ore:
434.81K
Relative Volume:
0.84
Capitalizzazione di mercato:
$5.52B
Reddito:
$4.89B
Utile/perdita netta:
$-263.00M
Rapporto P/E:
-20.17
EPS:
-0.7734
Flusso di cassa netto:
$-167.84M
1 W Prestazione:
+0.32%
1M Prestazione:
+3.11%
6M Prestazione:
+35.06%
1 anno Prestazione:
-20.29%
Intervallo 1D:
$15.24
$15.87
Intervallo di 1 settimana:
$15.24
$16.81
Portata 52W:
$10.45
$20.71
Bausch Lomb Corp Stock (BLCO) Company Profile
Nome
Bausch Lomb Corp
Settore
Industria
Telefono
908-541-5456
Indirizzo
520 APPLEWOOD CRESCENT, VAUGHAN
Confronta BLCO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BLCO
Bausch Lomb Corp
|
15.60 | 5.56B | 4.89B | -263.00M | -167.84M | -0.7734 |
|
ISRG
Intuitive Surgical Inc
|
549.51 | 200.47B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.04 | 55.33B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
77.65 | 38.61B | 10.19B | 1.05B | 1.39B | 2.1065 |
|
RMD
Resmed Inc
|
244.46 | 36.80B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
261.36 | 19.18B | 2.96B | 487.70M | 344.00M | 6.6758 |
Bausch Lomb Corp Stock (BLCO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-01 | Iniziato | Goldman | Neutral |
| 2025-05-02 | Reiterato | H.C. Wainwright | Buy |
| 2025-03-28 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2024-12-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-10-15 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2024-07-10 | Iniziato | Raymond James | Outperform |
| 2024-05-06 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-12-12 | Iniziato | Stifel | Hold |
| 2023-10-03 | Ripresa | Evercore ISI | Outperform |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-03-09 | Iniziato | Needham | Hold |
| 2022-12-21 | Iniziato | Barclays | Equal Weight |
| 2022-09-12 | Iniziato | H.C. Wainwright | Buy |
| 2022-07-26 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-06-24 | Iniziato | Evercore ISI | Outperform |
| 2022-06-06 | Iniziato | Citigroup | Buy |
| 2022-05-31 | Iniziato | Deutsche Bank | Hold |
| 2022-05-31 | Iniziato | Goldman | Neutral |
| 2022-05-31 | Iniziato | Guggenheim | Buy |
| 2022-05-31 | Iniziato | JP Morgan | Neutral |
| 2022-05-31 | Iniziato | Jefferies | Buy |
| 2022-05-31 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-05-31 | Iniziato | Wells Fargo | Overweight |
| 2022-05-11 | Iniziato | Cowen | Outperform |
Mostra tutto
Bausch Lomb Corp Borsa (BLCO) Ultime notizie
Does Bausch + Lomb Corporation (S2L) stock trade below intrinsic value2025 Fundamental Recap & Reliable Intraday Trade Alerts - newser.com
Cautious Hold Rating on Bausch + Lomb: Awaiting Catalysts for Stock Valuation Boost - TipRanks
Short interest data insights for Bausch + Lomb CorporationJuly 2025 Institutional & Weekly Top Performers Watchlists - newser.com
A Quick Look at Today's Ratings for Bausch + Lomb Corp.(BLCO.US), With a Forecast Between $13 to $19 - 富途牛牛
RBC Raises Price Target on Bausch + Lomb to $19 From $17, Keeps Outperform Rating - MarketScreener
Needham maintains Hold rating on Bausch & Lomb stock amid pipeline potential - Investing.com UK
Bausch & Lomb stock price target raised to $19 by RBC on margin outlook - Investing.com UK
Jefferies raises Bausch & Lomb stock price target to $20 on strong growth outlook - Investing.com UK
Can Bausch + Lomb Corporation (S2L) stock sustain double digit ROE2025 Bull vs Bear & Verified Entry Point Detection - newser.com
How strong is Bausch + Lomb Corporation stock revenue growth2025 Biggest Moves & AI Powered Buy and Sell Recommendations - newser.com
Can Bausch + Lomb Corporation stock resist sector downturns2025 Short Interest & Real-Time Volume Spike Alerts - newser.com
Using data models to predict Bausch + Lomb Corporation stock movementMarket Volume Summary & Fast Exit and Entry Strategy Plans - newser.com
Earnings visualization tools for Bausch + Lomb CorporationForecast Cut & AI Based Buy and Sell Signals - newser.com
Why Bausch + Lomb Corporation stock could see breakout soonMarket Sentiment Review & Safe Swing Trade Setup Alerts - newser.com
Bausch + Lomb Sets Ambitious Growth Targets At Investor Day - Finimize
Bausch + Lomb Brief: Will Unveil Plans to Achieve "Above-market revenue growth and meaningful margin expansion" - MarketScreener
Bausch + Lomb Brief: Said To Highlight Company "Transformation And Growth Strategy" At Investor Day Today - MarketScreener
Bausch + Lomb sets 5-7% revenue growth target through 2028 By Investing.com - Investing.com South Africa
Bausch + Lomb Unveils Strategic Growth Plan at Investor Day - TipRanks
Bausch + Lomb to Highlight Company Transformation and Growth Strategy at Investor Day - The Joplin Globe
New Eye Tech Is Booming For Alcon, Stock Soars - Benzinga
(BLCO) Trading Advice (BLCO:CA) - news.stocktradersdaily.com
Will Bausch + Lomb Corporation stock benefit from Fed rate cutsInsider Selling & Verified Entry Point Signals - newser.com
What is the fair value estimate for Bausch + Lomb Corporation (S2L) stock in 20252025 Market WrapUp & High Accuracy Swing Entry Alerts - newser.com
What margin trends mean for Bausch + Lomb Corporation stockCPI Data & Weekly Breakout Watchlists - newser.com
Real time breakdown of Bausch + Lomb Corporation stock performance2025 Historical Comparison & Expert Verified Stock Movement Alerts - newser.com
Stocks in play: Bausch + Lomb Corporation - The Globe and Mail
Bausch + Lomb (NYSE: BLCO) ONE by ONE Recycling totals 691,180 lbs, 114,037,136 units - Stock Titan
Medical Devices & SuppliesSpecialty Stocks Q3 In Review: Bausch + Lomb (NYSE:BLCO) Vs Peers - Yahoo Finance
Bausch + Lomb Corporation’s Growth Surge: Can New Contact Lens Tech Grab A Larger Chunk Of The Market? - Smartkarma
(BLCO) Strategic Market Analysis (BLCO:CA) - news.stocktradersdaily.com
Will Pharmaceuticals Division Momentum and Updated Outlook Shift Bausch + Lomb's (BLCO) Investment Narrative? - Yahoo Finance
Bausch Lomb Corp Azioni (BLCO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.23%
0.58%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):